M. De Smet

Publication List Details

Period

1992 - 2008

Number

50

Co-Authors

Multiple-dose pharmacodynamics and pharmacokinetics of Anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects (2008)

Krishna, R, Bergman, A, Jin, B, Fallon, M, Cote, J, Van Hoydonck, P, ...

Cholesteryl ester transfer protein (CETP) is a plasma protein that catalyzes the heteroexchange of cholesteryl esters from high-density lipoprotein (HDL) and trglycerides to apolipoprotein...

Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A)alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers (2007)

De Visser, S. J, Van Der Post, J. P, De Smet, M, Schoemaker, R. C, Rijnbeek, B, ...

TPA023, a GABA(A) alpha 2,3 alpha subtype-selective partial agonist, is expected to have comparable anxiotytic efficacy as benzodiazepines with reduced sedating effects. The compound lacks efficacy...

Influence of life stress on immunological reactivity to mild psychological stress (2007)

Brosschot, J F, Benschop, R J, Godaert, G L, Olff, M, De Smet, M, Heijnen, C J, ...

This study investigated the effects of self-reported life stress and locus of control on reactivity of several immune parameters to a mild and short-lasting interpersonal stressor. Subjects were 86...

Interaction between vinblastine and ionizing radiation in the mouse MO4 fibrosarcoma in vivo (2007)

Van Belle, S, Fortan, L, De Smet, M, De Neve, W, Storme, G

The effect of combining vinblastine (VLB) and ionizing radiation (IR) on tumor response was investigated in CDF1 mice bearing the MO4 mouse fibrosarcoma. Favorable interactions were assumed to occur...

Earthquakes and crush syndrome casualties: lessons learned from the Kashmir disaster (2007)

Vanholder, R, De Smet, M, Hoste, E, Koç, M, Hussain, A, ...

Major earthquakes may provoke a substantial number of crush casualties complicated by acute kidney injury (AKI). After the 1988 Armenian earthquake, the International Society of Nephrology (ISN)...

Improving method capability of a drug substance HPLC assay (2006)

Dejaegher, B, Jimidar, M, De Smet, M, Cockaerts, P, Smeyers-Verbeke, J, Vander Heyden, Y

The assay of a drug substance (DS) is one of the tests required to confirm the active pharmaceutical ingredient (API) quality at release. In the past, usually volumetric titration methods were...

Stationary phases in the screening of drug/impurity profiles and in their separation method development: identification of columns with different and similar selectivities (2006)

Van Gyseghem, Elke; U0049174, Jimidar, M, Sneyers, R, De Smet, M, Verhoeven, E, Vander Heyden, Y

The classification or characterization of stationary phases based on chromatographic parameters, in general, requires different test solutes/mixtures and several mobile phases. To simplify the...

Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteers (2006)

Bergman, AJ, Stevens, C, Zhou, YY, Yi, BM, Laethem, M, De Smet, M, ...

Background: Dipeptidyl peptidase-IV (DPP-IV) inhibitors represent a new class of oral antihyperglycemic agents. Sitagliptin is an orally active and selective DPP-IV inhibitor currently in Phase III...

Laser diffraction and image analysis as a supportive analytical tool in the pharmaceutical development of immediate release direct compression formulations (2005)

Tinke, A P, Vanhoutte, K, Vanhoutte, F, De Smet, M, De Winter, H

Immediate release direct compression tablet formulations require a strict control of the particle characteristics (i.e. particle size (distribution) and shape) of both the active pharmaceutical...

Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients (2005)

Nygren, P, Hande, K, Petty, KJ, Fedgchin, M, Van Dyck, K, Majumdar, A, ...

Background: Aprepitant is a selective neurokinin-1 receptor antagonist that is effective for the prevention of nausea and vomiting caused by highly emetogenic chemotherapy. In vitro, aprepitant is a...

A screening strategy for the development of enantiomeric separation methods in capillary electrophoresis (2004)

Jimidar, ML, Van Ael, W, Van Nyen, P, Peeters, M, Redlich, D, De Smet, M

Method development of enantiomeric separations in capillary electrophoresis (CE) is a time-consuming task, since finding the appropriate chiral selector is usually a "trial and error" process. It is...

Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869 (2002)

Lichinitser, MR, Navari, RM, Garin, AM, Decramer, Marc; U0004666, Riviere, A, ...

BACKGROUND: Recent studies have suggested that antiemetic therapy with a triple combination of the neurokinin-1 receptor antagonist MK-869, a serotonin (5-HT(3)) antagonist, and dexamethasone...

Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis (2001)

Van Belie, S, Reinhardt, RR, O'Brien, M, Schellens, JHM, ...

Substance P is localised ill brainstem regions associated with emesis. Based on studies in the ferret, it was postulated that a neurokinin-1 (NK1) receptor antagonist would have antiemetic activity...

Effect of rofecoxib on the pharmacokinetics of digoxin in healthy volunteers (2001)

Schwartz, JI, De Smet, M, Larson, PJ, Verbesselt, René; U0018460, Ebel, DL, Lins, R, ...

The authors examined the effect of the cyclooxygenase-2 (COX-2) inhibitor, rofecoxib, at steady state on the pharmacokinetics of digoxin following a single dose in healthy subjects. Each healthy...

The effect of rofecoxib on the pharmacodynamics and pharmacokinetics of warfarin (2000)

Schwartz, JI, Bugianesi, KJ, Ebel, DL, De Smet, M, Haesen, R, Larson, PJ, ...

Objective: The objective of this study was to examine the effect of 3 doses of rofecoxib (12.5, 25, and 50 mg) on the pharmacodynamics and pharmacokinetics of warfarin.

Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteers (1999)

Lee, Y, Conroy, JA, Stepanavage, ME, Mendel, CM, Somers, Geert; U0048845, McLoughlin, DA, ...

Aims The pharmacokinetics and dose proportionality of rizatriptan single oral doses from 2.5 to 15 mg administered as solutions to healthy volunteers were studied.

Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females (1996)

Cheng, HY, Leff, JA, Amin, R, Gertz, BJ, De Smet, M, Noonan, N, ...

Purpose. The safety, tolerability, and pharmacokinetics of intravenous (i.v.) montelukast sodium (Singulair(TM), MK-0476), and the oral bioavailability of montelukast sodium in healthy males and...

Effect of multiple doses of losartan on the pharmacokinetics of single doses of digoxin in healthy volunteers (1995)

De Smet, M, Schoors, DF, DeMeyer, G, Verbesselt, René; U0018460, Goldberg, MR, Fitzpatrick, V, ...

1 Losartan (DuP 753, MK-954) is a novel, potent and highly selective AT(1) angiotensin II receptor antagonist. The effect of multiple oral doses of losartan on digoxin pharmacokinetics was evaluated...

Single-dose pharmacokinetics, safety and tolerability of mk-0476, a new leukotriene d-4-receptor antagonist, in healthy-volunteers (1995)

Schoors, Df, De Smet, M, Reiss, T, Margolskee, D, Cheng, H, Larson, P, ...

MK-0476 or sodium 1-(1(R)-(3-(2-(7-chloro-2-quinolinyl)-(E)-ethenyl)phenyl) 3-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cycloproprane) acetate is a novel, potent, and specific...

The effect of mk-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in-vivo (1995)

Diamant, Z, Timmers, Mc, Vanderveen, H, Friedman, Bs, De Smet, M, ...

Background: The 5-lipoxygenase metabolites of arachidonic acid are likely to be involved in the pathophysiology of atopic asthma. We investigated the effect of pretreatment with MK-0591, a novel...

Effect of Fluconazole on Indinavir Pharmacokinetics in Human Immunodeficiency Virus-Infected Patients

De Wit, S., Debier, M., De Smet, M., McCrea, J., Stone, J., Carides, A., ...

To evaluate a potential pharmacokinetic interaction of coadministration of fluconazole, and indinavir, a human immunodeficiency virus (HIV) protease inhibitor, 13 patients were enrolled in a...

Effect of Fluconazole on Indinavir Pharmacokinetics in Human Immunodeficiency Virus-Infected Patients

De Wit, S., Debier, M., De Smet, M., McCrea, J., Stone, J., Carides, A., ...

To evaluate a potential pharmacokinetic interaction of coadministration of fluconazole, and indinavir, a human immunodeficiency virus (HIV) protease inhibitor, 13 patients were enrolled in a...

Single dose pharmacokinetics, safety and tolerability of MK-0476, a new leukotriene D4-receptor antagonist, in healthy volunteers.

Schoors, D F, De Smet, M, Reiss, T, Margolskee, D, Cheng, H, Larson, P, ...

MK-4076 or sodium 1-(1(R)-(3-(2-(7-chloro-2-quinolinyl)-(E)- ethenyl)phenyl) 3-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl) cycloproprane) acetate is a novel, potent, and specific...

Effect of multiple doses of losartan on the pharmacokinetics of single doses of digoxin in healthy volunteers.

De Smet, M, Schoors, D F, De Meyer, G, Verbesselt, R, Goldberg, M R, Fitzpatrick, V, ...

1. Losartan (DuP 753, MK-954) is a novel, potent and highly selective AT1 angiotensin II receptor antagonist. The effect of multiple oral doses of losartan on digoxin pharmacokinetics was evaluated...